This year’s AACC was one of the biggest exhibitions and conferences in the history of American Association of Clinical Chemistry.
The 69th AACC Clinical Lab Expo featured 789 exhibitors and covered 246,000 net square feet, also making this the largest show floor in AACC’s history. As of Wednesday, August 2, more than 21,300 laboratory medicine professionals and healthcare leaders had registered for the meeting, which is a 7.9% increase over meeting attendance in 2016 and the highest number of attendees that have come to the meeting in its history.
Health Gene Technologies took part in the event fourth year in a row. This exhibition focused on demonstrating the mature product of clinical diagnostics, the star of the forensic science, and the RUO products in HGT pipeline.
Respiratory pathogen infection is one of the most common clinical diseases, causing millions of mortality worldwide every year. In the global appeal to reduce the abuse of antibiotics, a clear identification of respiratory infection pathogens and then targeted treatment help to alleviate the serious problem of antibiotic abuse. Health Gene Technologies’SureX® 13 Respiratory Pathogen Multiplex Kit covering 11 common respiratory viruses, chlamydia and Mycoplasma pneumoniae. Compared to other products on the market, this kit has advantagesof being comprehensive, multiplex in one tube, triple quality controls, and accurate results.
World-wide epidemiological studies have shown that cervical cancer is the second most common malignant disease in women. High-risk oncogenic HPV (Human papillomavirus) types (including HPV 16 and HPV 18) are associated with 99.7% of all cervical cancers, indicating that the presence of HPV is an obligatory element in the development of cervical cancer. Persistent infection with high-risk HPV types may progress to precancerous lesions, which is the root cause of nearly all cases of cervical cancer. HGT’s SureX® HPV 25X Genotyping Kit can detect and genotype25 HPV typessimultaneously.
During the three-day exhibition, HGT attracted many visitors discussing the possible directions of follow-up work.
HGT is committed to developing and manufacturing simple, rapid and effective nucleic acid (DNA) testing solutions for molecular diagnostics, clinical research and forensic analysis.